Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- Total serum bilirubin
研究概览
简要总结
This project aims to test a novel smartphone application, Picterus, which provides a cheaper, patient-friendly, and more readily means of neonatal jaundice detection. For this purpose, the study aims to collect data from newborns with a broad range of bilirubin levels and high melanin content in a population in Botswana.
详细描述
Neonatal jaundice is a condition in newborns with elevated levels of the waste product bilirubin, also known as hyperbilirubinemia. It is primarily caused by a combination of the rapid turnover of red blood cells and the immature liver functions in the newborn. Neonatal jaundice affects approximately 60 to 80 % of newborns but is usually self-limiting and harmless. The condition is still potentially dangerous because bilirubin can accumulate in the basal ganglia of the brain, where it can cause permanent brain damage. Such brain damage, better known as kernicterus, can manifest as cerebral palsy, deafness, language difficulty, or in the worst cases, be fatal.
This study will be conducted at a hospital in Botswana, where the study aim to collect data from newborns with a broad range of bilirubin levels and high melanin content.
The investigators hypothesize that the Picterus JP will offer bilirubin level estimates that are highly correlated to bilirubin levels measured in blood samples in a population in Botswana. Following our hypothesis, the short-term goal for this project is to demonstrate that this screening method can be used to identify children with severe neonatal jaundice independent of skin color. Thus, providing a cheaper, patient-friendly, and more readily available means of neonatal jaundice detection.
The study will be a diagnostic accuracy cross-sectional study with quantitative methods of data collection.
The study population will comprise 150 newborns from the Neonatal Unit and the postnatal ward at Princess Marina Hospital, a number determined by a sample size calculation based on standard errors of the 95% limit agreement, as described by Bland and Alman.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 24 Hours 至 14 Days(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Gestational age > 37 weeks
- •Birth weight > 2000 g and < 4500 g
- •Age > 24 hours and < 14 days
- •Infants requiring a blood sample for clinically suspected jaundice or other screening
排除标准
- •Infants transferred to the pediatric ward for advanced treatment
- •Infants with a skin rash or other disease that affects the skin where measurements are performed
- •Infants that receive or have received phototherapy in the last 24 hours
- •Infants with an inborn disease
结局指标
主要结局
Total serum bilirubin
时间窗: Must be performed within 1 hour of measurement with smartphone app and transcutaneous bilirubinometer
Total serum bilirubin determined by a blood sample
Picterus app estimate
时间窗: Must be performed within 1 hour of blood sample
Estimate of total serum bilirubin in the blood by a smartphone app
次要结局
- Transcutaneous bilirubin(Must be performed within 1 hour of blood sample)
研究者
Julie Zimmer
Principal investigator
Hillerod Hospital, Denmark
